Think New, Think Deep

Act Now, Act Together

LSK INVESTMENT

ABOUT US

LSK investment, one of the leading Korean venture capital firms, provides long-term capital and management support to promising venture enterprises managed by sincere entrepreneurs. Our mission is two-fold. One is to provide a professional, long-term financial support to promising venture companies with high technologies in order to help them pursue continuous business growth. The other is to generate a long-term capital appreciation for our investors. To accomplish our mission, we have assembled the team of highly experienced professionals who bring not only deep domain expertise but also hands-on operating experience to the portfolio companies. We support investee companies with management consulting and unique network. Having these capabilities, we invest in advanced technology companies in pharmaceutics, medical devices and medical services.

CEO 흑백이미지
CEO 이미지

CEO’S GREETING

Kim, Myung Kee
Chief Executive Officer
Education

Master of Business Administration, Sogang University

Doctor of Philosophy in Biological Science, KAIST

Master of Science in Biotechnology, KAIST

Bachelor of Science in Food Science & Technology, Seoul National University

Career

InterVest

Green Technology Investment

Q Capital Partners

LG Chem

TEAM

Professionals

  • HAN,SANG YUP

    Executive Vice President
    Education

    MBA, KAIST

    M.S in Biology, Yonsei University

    B.S in Biology, Yonsei University

    Career

    InterVest

    KTBNetwork

    AGBioDiagnostics

  • LEE, MYUNG GWON

    Managing Director
    Education

    Ph.D. in Bio and Brain Engineering, KAIST

    M.S in Bio and Brain Engineering, KAIST

    B.E in Electrical and Electronic Engineering, Jeonbuk National University

    Career

    MiraeAsset Capital,

    ID Ventures

    Intellectual Discovery

    LG Electronics

  • LEE, YOUNG HUN

    Managing Director
    Education

    Ph.D. in Life Sciences,
    The University of Tokyo

    M.S in Life Sciences,
    The University of Tokyo

    B.S in Life Sciences,
    Rikkyo University

    Career

    Medici Investment

    Green Cross

    DONG-A PHARM

  • YUN, DOO CHUN

    Director
    Education

    MBA, KAIST

    M.S in Pharmacy,
    Chung-Ang University

    B.S in Pharmacy,
    Chung-Ang University

    Career

    Comes Investment

    HB Investment

    Kolon Life Science

    Bi-nex

  • CHUN, MIN JEONG

    Manager
    Education

    B.S in Biological Sciences, KAIST

  • YU, BYEONG HO

    Manager
    Education

    B.S in Pharmacy, Busan National University (Pharm. D.)

    Career

    Lee & Mock IP Law Firm (Patent Attorney)

Compliance

  • HEO, YONG

    Auditor
    Education

    MBA, Columbia University

    BA. Economics,
    Seoul National University

    Career

    Green Technology Investment

Operations

  • LEE, JIN SUN

    Director
  • HAN, SEUNG A

    Assistant Manager
  • LEE, SU YEON

    Associate

INVESTMENT PHILOSOPHY

  • img
    Integrity

    LSK investment understands that integrity is the most influential attribute in regard to the success of a business, and abides by the value.

  • img
    Transparency

    LSK investment believes in the significance of transparency in managing fund, and thus periodically keeps our clients informed of important information.

  • img
    Focused Fund System

    LSK investment, to perform the role of a “prudent fund manager”, has adopted the primary fund s ystem which may get rid of potential conflict of interests.

INVESTMENT PROCESS

  • 1 icon

    Receive investment
    counseling

  • 2 icon

    Review business plan
    interview with reviewers

  • 3 icon

    Business fair (IR)

  • 4 icon

    Due diligence

  • 5 icon

    Investment review
    committee

  • 6 icon

    Conclusion of contract
    and obligation of fund

  • 7 icon

    follow-up support

Funds Under Management

  • 38.5bil KRW

    2016

    LSK-BNH Korea Bio Fund
  • 20bil KRW

    2017

    LSK Healthcare Fund No.1
  • 45bil KRW

    2019

    LSK Healthcare Fund No.2

  • 55bil KRW

    2020

    Smart LSK Fund No.3
  • 17.5bil KRW

    2022

    LSK Healthcare Fund No.4
  • 46bil KRW

    2022

    LSK Healthcare Fund No.5

Funds Liquidated

  • 6.1bil KRW

    2018

    LSK Private Equity Fund No.1

CONTACT